Prelude Therapeutics (PRLD) Stock Insights

PRLD price $3.97 +0.09 +2.32%

Ticker
PRLD
Price
$3.97
Change
+0.09 +2.32%
Market cap ?
$229.78M
P/E ?
-4.68
Forward P/E ?
18.05
Dividend yield ?
0.00%
Beta ?
0.96
Sector
Healthcare
Industry
Biotechnology

Financials

20182019202020212022202320242025
000000700000012140000

Prelude Therapeutics, Inc. is a clinical-stage precision oncology company focused on identifying and developing innovative, targeted cancer treatments for patient populations with unmet medical needs. Its pipeline includes PRT543, currently undergoing Phase 1 clinical evaluation for certain solid tumors and myeloid malignancies. Another asset, PRT811, is also in Phase 1 trials, targeting various solid tumors…

Fair value

PRLD fair value $8.60. Price $3.97. Price is 54% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare PRLD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—0.00—29.00M
2026-08-11-0.14-0.205.70M5.70M
2026-05-12-0.13-0.274.58M4.58M
2026-03-10-0.20-0.335.60M20.50M
2025-11-12-0.26-0.356.50M20.50M
2025-08-14-0.41-0.45——
2025-05-06-0.42-0.47——
2025-03-10-0.38-0.484.00M—
2024-11-06-0.43-0.473.00M—
2024-08-12-0.46-0.43——
2024-05-07-0.42-0.48——
2024-02-15-0.46-0.49——
2023-11-01-0.45-0.58——
2023-08-03-0.54-0.63——
2023-05-08-0.58-0.68——
2023-03-15-0.60-0.63——
2022-11-14-0.63-0.64——
2022-08-09-0.58-0.61——
2022-05-10-0.63-0.65——
2022-03-16-0.71-0.68——
2021-11-12-0.66-0.62——
2021-08-12-0.58-0.49——
2021-05-11-0.47-0.42——
2021-03-16-0.45-0.47——
2020-11-10-5.25-0.43——
2020-09-25-0.30———
2019-12-31-0.31———
2019-09-30-0.21———
2019-06-30-3.42———
2019-03-31-3.42———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-09BAKER BROS. ADVISORS LPBuy38.00K$3.94149.72K
2026-06-09Dorton KatinaBuy38.00K$3.94149.72K
2026-06-09Babler MartinBuy38.00K$3.94149.72K
2026-06-09Bonita David PBuy38.00K$3.94149.72K
2026-06-09Sandor VictorBuy38.00K$3.94149.72K
2026-06-09FRIEDMAN PAUL ABuy38.00K$3.94149.72K
2026-05-01Morris Charles QBuy450.00K$4.702.12M
2026-04-27RA CAPITAL MANAGEMENT, L.P.Sell1.41M$0.00141
2026-04-27RA CAPITAL MANAGEMENT, L.P.Buy1.41M$0.00141
2026-04-21RA CAPITAL MANAGEMENT, L.P.Other0——
2026-04-21Bonita David PBuy1.69M$4.447.50M
2026-04-21Bonita David PBuy1.13M$4.445.00M
2026-04-21ORBIMED ADVISORS LLCBuy1.69M$4.447.50M
2026-04-21ORBIMED ADVISORS LLCBuy1.13M$4.445.00M
2026-04-21BAKER BROS. ADVISORS LPBuy2.14M$0.00214
2026-04-21BAKER BROS. ADVISORS LPBuy114.60K$0.0011
2026-04-15Morris Charles QOther0——
2026-03-05Brusky Sean P.Other0——
2026-03-05Brusky Sean P.Other275.00K——
2026-02-04Combs AndrewBuy230.00K$2.30529.00K
2026-02-04Scherle PeggyBuy230.00K$2.30529.00K
2026-02-04Lim Bryant DavidBuy275.00K$2.30632.50K
2026-02-04Vaddi KrishnaBuy837.00K$2.301.93M
2025-11-05Sandor VictorBuy121.28K$1.39168.59K
2025-10-17Dorton KatinaOther0——
2025-10-04Huang JaneBuy9.38K——
2025-10-04Huang JaneSell3.35K$1.474.93K
2025-10-04Huang JaneSell9.38K——
2025-07-04Huang JaneBuy9.38K——
2025-07-04Huang JaneSell3.35K$0.792.66K
2025-07-04Huang JaneSell9.38K——
2025-06-12BAKER BROS. ADVISORS LPBuy76.00K$1.0479.04K
2025-06-12Scherer Paul COther0——
2025-06-12Sandor VictorBuy38.00K$1.0439.52K
2025-06-12Dier MardiBuy38.00K$1.0439.52K
2025-06-12FRIEDMAN PAUL ABuy38.00K$1.0439.52K
2025-06-12Bonita David PBuy38.00K$1.0439.52K
2025-06-12Babler MartinBuy38.00K$1.0439.52K
2025-04-04Huang JaneBuy9.38K——
2025-04-04Huang JaneSell3.35K$0.682.26K
2025-04-04Huang JaneSell9.38K——
2025-03-25Combs AndrewBuy100.00K$0.6969.25K
2025-03-25Vaddi KrishnaBuy675.00K$0.69467.44K
2025-03-21Vaddi KrishnaBuy15.00K$0.7310.96K
2025-03-20Vaddi KrishnaBuy5.42K$0.733.95K
2025-03-17Vaddi KrishnaBuy9.11K$0.756.83K
2025-03-14Vaddi KrishnaBuy30.00K$0.7522.63K
2025-03-13Vaddi KrishnaBuy50.00K$0.7235.82K
2025-03-12Vaddi KrishnaBuy47.50K$0.7133.74K
2025-02-04Lim Bryant DavidBuy200.00K$1.11222.00K
2025-02-04Scherle PeggyBuy175.00K$1.11194.25K
2025-02-04Combs AndrewBuy175.00K$1.11194.25K
2025-02-04Huang JaneBuy200.00K$1.11222.00K
2025-02-04Vaddi KrishnaBuy496.00K$1.11550.56K
2025-01-04Huang JaneBuy9.38K——
2025-01-04Huang JaneSell3.86K$1.395.36K
2025-01-04Huang JaneBuy9.38K——
2024-12-31Vaddi KrishnaBuy5.00K$1.216.04K
2024-12-30Vaddi KrishnaBuy10.00K$1.2012.00K
2024-12-23Combs AndrewBuy60.00K$1.3782.00K
2024-12-20Combs AndrewBuy3.08K$1.153.54K
2024-12-19Lim Bryant DavidBuy25.00K$0.9122.64K
2024-12-19Vaddi KrishnaBuy6.89K$0.896.12K
2024-12-18Vaddi KrishnaBuy100.00K$0.9393.21K
2024-07-04Huang JaneSell9.38K——
2024-07-04Huang JaneBuy9.38K——
2024-07-04Huang JaneSell3.35K$3.6012.05K
2024-06-14BAKER BROS. ADVISORS LPBuy23.50K$3.9091.65K
2024-06-14Sandor VictorBuy23.50K$3.9091.65K
2024-06-14FRIEDMAN PAUL ABuy23.50K$3.9091.65K
2024-06-14Dier MardiBuy23.50K$3.9091.65K
2024-06-14Bonita David PBuy23.50K$3.9091.65K
2024-06-14Babler MartinBuy23.50K$3.9091.65K
2024-05-14Lim Bryant DavidBuy25.00K$3.8696.50K
2024-04-04Huang JaneSell9.38K——
2024-04-04Huang JaneBuy9.38K——
2024-04-04Huang JaneSell3.35K$4.7415.86K
2024-03-01Lim Bryant DavidBuy150.00K$4.59688.50K
2024-03-01Scherle PeggyBuy150.00K$4.59688.50K
2024-03-01Combs AndrewBuy150.00K$4.59688.50K
2024-03-01Chardonnet LaurentBuy150.00K$4.59688.50K
2024-03-01Huang JaneBuy175.00K$4.59803.25K
2024-03-01Vaddi KrishnaBuy425.00K$4.591.95M
2024-01-04Huang JaneSell9.38K——
2024-01-04Huang JaneBuy9.38K——
2024-01-04Huang JaneSell3.84K$3.7714.49K
2023-12-13BAKER BROS. ADVISORS LPBuy7.34M$0.00734
2023-12-13BAKER BROS. ADVISORS LPBuy593.45K$0.0059
2023-10-04Huang JaneBuy9.38K——
2023-10-04Huang JaneBuy9.38K——
2023-07-04Huang JaneSell9.38K——
2023-07-04Huang JaneBuy9.38K——
2023-07-04Huang JaneSell3.24K$4.6515.08K
2023-06-16BAKER BROS. ADVISORS LPBuy23.50K$5.56130.66K
2023-06-16Sandor VictorBuy23.50K$5.56130.66K
2023-06-16FRIEDMAN PAUL ABuy23.50K$5.56130.66K
2023-06-16Dier MardiBuy23.50K$5.56130.66K
2023-06-16Bonita David PBuy23.50K$5.56130.66K
2023-06-16Babler MartinBuy23.50K$5.56130.66K
2023-05-25Vaddi KrishnaBuy900$5.314.78K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 83, holders +27 vs prior quarter. Ownership 50.48%.

HolderSharesChangeChange %Value
ORBIMED ADVISORS LLC13.72M2.82M+25.81%73.15M
BAKER BROS. ADVISORS LP10.12M00.00%53.96M
RA CAPITAL MANAGEMENT, L.P.6.48M6.48MNew34.52M
SOLEUS CAPITAL MANAGEMENT, L.P.3.38M3.38MNew18.01M
KYNAM CAPITAL MANAGEMENT, LP2.42M822.54K+51.65%12.87M
VANGUARD CAPITAL MANAGEMENT LLC2.01M779.04K+63.32%10.71M
BLACKROCK, INC.1.80M1.48M+458.43%9.58M
SPHERA FUNDS MANAGEMENT LTD.1.02M461.49K+82.65%5.44M
TWO SIGMA INVESTMENTS, LP993.37K69.74K+7.55%5.29M
ADAR1 CAPITAL MANAGEMENT, LLC900.90K748.08K+489.50%4.80M
MILLENNIUM MANAGEMENT LLC844.99K462.26K+120.78%4.50M
GEODE CAPITAL MANAGEMENT, LLC841.86K539.40K+178.34%4.49M
ADAGE CAPITAL PARTNERS GP, L.L.C.766.10K766.10KNew4.08M
ACADIAN ASSET MANAGEMENT LLC611.36K99.84K+19.52%3.25M
MORGAN STANLEY503.86K181.70K+56.40%2.69M
STATE STREET CORP428.79K290.56K+210.20%2.29M
UBS GROUP AG318.80K254.29K+394.22%1.70M
VANGUARD FIDUCIARY TRUST CO284.89K127.51K+81.02%1.52M
RENAISSANCE TECHNOLOGIES LLC281.20K6.00K+2.18%1.50M
NORTHERN TRUST CORP240.60K190.48K+380.05%1.28M
VANGUARD PORTFOLIO MANAGEMENT LLC193.92K193.92KNew1.03M
MARSHALL WACE, LLP190.69K-168.21K-46.87%1.02M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.125.61K16.52K+15.15%669.48K
GOLDMAN SACHS GROUP INC120.83K-115.64K-48.90%644.04K
SUSQUEHANNA INTERNATIONAL GROUP, LLP111.00K111.00KNew591.63K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Prelude Therapeutics (PRLD) Stock Insights

PRLD$3.97+0.09 +2.32%

$229.78M

Market Cap

-4.68

P/E

18.05

Forward P/E

—

Score

Price History